Pomalid - 1mg



Describe As


Pomalid 1 mg is therapeutically categorized as an anti-neoplastic agent, which is active in multiple myeloma condition. Pomalid 1 mg capsules are used by the patients who are having a prescription specify by practiced medical oncologist. Pomalid 1 mg capsules are indicated in the patients who are already receiving Lenalidomide & proteasome inhibitors. Pomalid 1 mg capsules are endorsed by FDA and which is applicable as orally bioavailable. Pomalid 1 mg contains Pomalidomidewhich is act as anti-cancer agent. Pomalidomideis a thalidomide analogue with efficient activities like; Anti-angiogenesis, Immuno modulatory & anti-neoplastic activity Pomalid 1 mg capsules are available in various strengths like 1mg, 2mg, and 4mg.


Dosage & Administration

The most common indication of Pomalid is involved in the treatment of Multiple Myeloma condition. The usual advised dose of Pomalid is 4mg tablet should be administered orally as once a day for cycles of 1 to 21 days for ensuing 28 day cycles. During this treatment, Pomalid should be combinely used with low dose of dexamethasone. Dexamethasone should be administered on day 1, 8, 15 & 22 of every 28 days cycles. The recommended dose of dexamethasone;





ADME


Pomalid 1 mg peak plasma concentration time: 2 to 3 hours Pomalid 1 mg capsules should be administered with or without food. Apparent volume of distribution 62 & 138L Human plasma protein binding capacity is 12% & 44%. Metabolism initiated by CYP1A2 & CYP3A4. Clearance value 7 to 10L/hr Elimination occurs through feces & urine by 18% & 73%. The unchanged form of Pomalid 1 mg should be excreted via urine & feces by 2% & 8%. Half life period of Pomalid 1 mg is 9.5 hours.

Concomitant use of CYP1A2 with Pomalid


In case of combination of Pomalid with CYP1A2 causes increasing the plasma concentration of Pomalidomide and leads to cause increased adverse effects. In this condition, reduce the dose of Pomalid.

In hepatic damaged patients;


Mild to moderate hepatic damage: The prescribed dose is 3mg of Pomalid should be taken. Severe liver damage: The prescribed dose is 2mg of Pomalid should be taken.

In renal damaged patients;


In severe renal damage condition, the suggested dose is 3mg per day.

safety Precaution


During Pomalid 1 mg treatment, patients should be very cautiously taking the doses. Two major life threatening conditions are occurred at the time of therapy; Venous & arterial thromboembolism Embryo fetal damage To avoid such conditions, patient should be taken some precautions like;

Embryo fetal toxicity


Pomalid 1 mg should not be used during pregnancy period. It comes under the category of X; may causes fetal toxic & leads to death. Use some special contraceptive techniques for preventing pregnant during the treatment. Pomalid 1 mg may causes Teratogenecity, organogenesis & this may concludes as fetal damage.

Venous & arterial thromboembolism


Deep vein thrombosis is the one of the major exposure occurs during the therapy of Pomalid 1 mg. To overcome the problem, thromboprophylaxis is initiated. In case of combination of pembrolizumab with thalidomide analogues & dexamethasone causes increasing rate of mortality. Especially in multiple myeloma adverse condition, this pembrolizumab with dexamethasone causes death rate in higher levels.

Hematological toxicity


The most common hematological disorders are neutropenia, & thrombocytopenia which may occurs during the treatment using with Pomalid 1 mg. Reduce this type of effect by undergoing CBC counts frequently and monitor the patients manifestation due to this adverse.

Hepatic toxicity


Hepatic associated adverse effects are mostly produced by elevation of hepatic enzymes levels. This may leads to severe hepatic failure. This condition may overcome by monitoring the patients hepatic function test regularly.

Neuropathy


These neurological problems are produces during the Pomalid 1 mg treatment by combining with dexamethasone. The therapy should be postponed for some period of time like, toxicity grade alters to 0. Second primary malignancies are most probably occurred in the patients who are receiving Pomalid 1 mg capsules.

Tumor lysis syndrome


During this adverse condition, Pomalid 1 mg therapy should be interrupt and follow the general supportive measures for the patients. Then the signs & symptoms occur due to this TLS should be monitored.

Therapeutic Indication


The therapeutic indication of Pomalid 1 mg is involved in condition like Multiple myeloma. In this condition, Pomalid 1 mg is utilized by consolidating with dexamethasone. Pomalid 1 mg cases are relevant in; Patients formerly regarded with two treatments, for example, proteasome inhibitor and Lenalidomide. Patients who are endured with illness movement condition Pomalid 1 mg treatment ought to be taken after inside 60 days in patients who are finished up the last treatment.

How Pomalid 1 mg Works


Pomalidomidehas three noteworthy pharmacological exercises against tumor cells. Pomalidomideincludes in impeding the malignancy duplication and creates the apoptosis of disease cells. Pomalidomideincrease the T cell and natural killer cells interceding insusceptibility and forbid the development of professional provocative cytokines from monocytes. Pomalidomideobstructs the new cell development. The official of Pomalidomideto dynamic site of focused cell causes restriction of ubiquitin ligase activity.

Drug Interaction


The concomitant use of Pomalid 1 mg with CYP1A2 potent inhibitors like Fluoxamine which will lead to elevate the plasma concentration of Pomalidomideand increases the adverse effects related to the Pomalid 1 mgomide. Stop the condition by reducing the Pomalid 1 mg dosage.

Storage


Pomalid 1 mg capsules container should be keep in a temperature of 20oC to 25oC. Do not store the container in light Protect from moisture & heat

Lactation


Breast feeding should not be recommended.

Pediatric


The potency & effectiveness of Pomalid 1 mg should not be evaluated.



Pregnancy


Pregnancy category of Pomalid 1 mg is categorized as X X means causes fetal damage during the Pomalid 1 mg treatment. Pomalid 1 mg causes embryo fetal damage.


Geriatric


Dose change of Pomalid 1 mg ought not to be suggested. Geriatric patients with time of over 65 years ought to be knowledgeable about pneumonia.


Contraindication


Pomalid 1 mg is contraindicated to pregnant women. Some anaphylactic reactions are occurs because patients are contraindicated to the component in the Pomalid 1 mg capsules.


Connect With Us

Prescription Medication Policy


1. Anti-Cancer-Drugs.com, a fully licensed and regulated pharmacy, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.
2. Anti-Cancer-Drugs.com will not dispense any prescription medication without a valid prescription from a licensed physician.
3. If you are ordering prescription medication(s), you hereby confirm that you will send us a scanned copy of your valid prescription(s) via email, fax, Whatsapp, or by post, and this prescription shall then be subject to the scrutiny of and approval by our qualified Pharmacists.
4. The drug information provided in the Anti-Cancer-Drugs.com is for informative purposes only and this Website is not intended to provide diagnosis, treatment or medical advice. We are not liable for any adverse effects or harm to you as a result of your reliance on the information in the Website.
5. Anti-Cancer-Drugs.com requires either the User or Customer or the Caregiver to confirm he/she is completely aware of the indications, side effects, drug interactions, effects of missed dose or overdose of the medicines he/she orders from us. It is imperative to seek professional advice from your physician before purchasing or consuming any medicine from Anti-Cancer-Drugs.com
6. At Anti-Cancer-Drugs.com, a Caregiver can order prescription medicines on your behalf.